who should not use glp 1 injections Compounded GLP-1 medications are trending online, but everything you hear is true. Your health deserves accurate information—not hype. Learn More: https://healthnothype.org/ #HealthNotHype #GLP1 #PatientSafety #HealthEducation #KnowTheFacts The ABC's of GLP-1s: Benefits,

Endocrine (2015) 48(1):10715.10.1007/s12020-014-0361-4 12 GilbertMPMarreMHolstJJGarberABaeresFMThomsenHet alComparison of the long-term effects of liraglutide and glimepiride monotherapy on bone mineral density in patients with type 2 diabetes

To complicate matters, microdosing programs typically rely on compounded versions of the medication, which carry their own risks

Retatrutide fails all of them: The FDA has said this directly: retatrutide "cannot be used in compounding under federal law." Any pharmacy making it is breaking federal law, no matter what their state laws say (Ohio Board of Pharmacy / FDA Letter)

For tirzepatide, with a similar half-life, the same guidance applies

In clinical trials, people lost an average of 9.4% to 14.7% of their body weight over 40 weeks

The main way GLP-1 RAs cause weight loss is by helping you eat less